{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T04:14:01Z","timestamp":1788149641394,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microsyst Nanoeng"],"DOI":"10.1038\/s41378-026-01437-4","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T03:24:36Z","timestamp":1788146676000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microarray chip to fabricate 3D PDAC heterospheroids with architectural organization towards tumor invasion and chemoresistance study"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-6884","authenticated-orcid":false,"given":"Xiaoyun","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingrun","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"1437_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41392-021-00659-4","volume":"6","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives. Signal Transduct. Target. Ther. 6, 249 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1437_CR2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3390\/diagnostics13040655","volume":"13","author":"MJ Amaral","year":"2023","unstructured":"Amaral, M. J. et al. Tumor stroma area and other prognostic factors in pancreatic ductal adenocarcinoma patients submitted to surgery. Diagnostics 13, 655 (2023).","journal-title":"Diagnostics"},{"key":"1437_CR3","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1053\/j.gastro.2012.11.037","volume":"144","author":"MV Apte","year":"2013","unstructured":"Apte, M. V., Wilson, J. S., Lugea, A. & Pandol, S. J. A starring role for stellate cells in the pancreatic cancer microenvironment. Gastroenterology 144, 1210\u20131219 (2013).","journal-title":"Gastroenterology"},{"key":"1437_CR4","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41419-022-05351-1","volume":"13","author":"T Zhang","year":"2022","unstructured":"Zhang, T., Ren, Y., Yang, P., Wang, J. & Zhou, H. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Cell Death.Dis. 13, 897 (2022).","journal-title":"Cell Death.Dis."},{"key":"1437_CR5","doi-asserted-by":"publisher","first-page":"114504","DOI":"10.1016\/j.addr.2022.114504","volume":"189","author":"R Rimal","year":"2022","unstructured":"Rimal, R. et al. Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting. Adv. Drug. Deliv. Rev. 189, 114504 (2022).","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"1437_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.trecan.2019.01.001","volume":"5","author":"J Schnittert","year":"2019","unstructured":"Schnittert, J., Bansal, R. & Prakash, J. Targeting pancreatic stellate cells in cancer. Trends Cancer 5, 128\u2013142 (2019).","journal-title":"Trends Cancer"},{"key":"1437_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho, W. J., Jaffee, E. M. & Zheng, L. The tumour microenvironment in pancreatic cancer-clinical challenges and opportunities. Nat. Rev. Clin. Oncol. 17, 527\u2013540 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1437_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canlet.2016.12.035","volume":"391","author":"J Kota","year":"2017","unstructured":"Kota, J., Hancock, J., Kwon, J. & Korc, M. Pancreatic cancer: stroma and its current and emerging targeted therapies. Cancer Lett 391, 38\u201349 (2017).","journal-title":"Cancer Lett"},{"key":"1437_CR9","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cell.2023.03.016","volume":"186","author":"Y Chhabra","year":"2023","unstructured":"Chhabra, Y. & Weeraratna, A. T. Fibroblasts in cancer: unity in heterogeneity. Cell 186, 1580\u20131609 (2023).","journal-title":"Cell"},{"key":"1437_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.semcancer.2021.03.006","volume":"82","author":"LNC Boyd","year":"2022","unstructured":"Boyd, L. N. C., Andini, K. D., Peters, G. J., Kazemier, G. & Giovannetti, E. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment. Semin. Cancer. Biol. 82, 184\u2013196 (2022).","journal-title":"Semin. Cancer. Biol."},{"key":"1437_CR11","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1038\/s41588-024-01914-4","volume":"56","author":"AM Khaliq","year":"2024","unstructured":"Khaliq, A. M. et al. Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneity. Nat. Genet. 56, 2455\u20132465 (2024).","journal-title":"Nat. Genet."},{"key":"1437_CR12","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","volume":"43","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics. Cancer. Cell. 43, 905\u2013924.e906 (2025).","journal-title":"Cancer. Cell."},{"key":"1437_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D \u00d6hlund","year":"2017","unstructured":"\u00d6hlund, D. et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J. Exp. Med. 214, 579\u2013596 (2017).","journal-title":"J. Exp. Med."},{"key":"1437_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"G Biffi","year":"2019","unstructured":"Biffi, G. et al. IL1-Induced JAK\/STAT Signaling Is Antagonized by TGF\u03b2 to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma. Cancer. Discov. 9, 282\u2013301 (2019).","journal-title":"Cancer. Discov."},{"key":"1437_CR15","doi-asserted-by":"publisher","first-page":"115670","DOI":"10.1016\/j.addr.2025.115670","volume":"225","author":"D Vaskovich-Koubi","year":"2025","unstructured":"Vaskovich-Koubi, D. et al. Patient-derived 3D-bioprinted models of pancreatic cancer: toward personalized therapy and overcoming tumor microenvironment challenges. Adv. Drug. Deliv. Rev. 225, 115670 (2025).","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"1437_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41378-020-00185-3","volume":"6","author":"V Velasco","year":"2020","unstructured":"Velasco, V., Shariati, S. A. & Esfandyarpour, R. Microtechnology-based methods for organoid models. Microsyst. Nanoeng. 6, 76 (2020).","journal-title":"Microsyst. Nanoeng."},{"key":"1437_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.5009\/gnl210166","volume":"16","author":"JH Lee","year":"2022","unstructured":"Lee, J. H. et al. Establishment of patient-derived pancreatic cancer organoids from endoscopic ultrasound-guided fine-needle aspiration biopsies. Gut. Liver. 16, 625\u2013636 (2022).","journal-title":"Gut. Liver."},{"key":"1437_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.trecan.2016.03.004","volume":"2","author":"LA Baker","year":"2016","unstructured":"Baker, L. A., Tiriac, H., Clevers, H. & Tuveson, D. A. Modeling pancreatic cancer with organoids. Trends Cancer 2, 176\u2013190 (2016).","journal-title":"Trends Cancer"},{"key":"1437_CR19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.actbio.2018.08.008","volume":"78","author":"G Lazzari","year":"2018","unstructured":"Lazzari, G. et al. Multicellular spheroid based on a triple co-culture: a novel 3D model to mimic pancreatic tumor complexity. Acta.Biomater. 78, 296\u2013307 (2018).","journal-title":"Acta.Biomater."},{"key":"1437_CR20","doi-asserted-by":"publisher","first-page":"e2102574","DOI":"10.1002\/adhm.202102574","volume":"11","author":"MV Monteiro","year":"2022","unstructured":"Monteiro, M. V., Rocha, M., Gaspar, V. M. & Mano, J. F. Programmable Living Units for Emulating Pancreatic Tumor-Stroma Interplay. Adv. Healthc.Mater. 11, e2102574 (2022).","journal-title":"Adv. Healthc.Mater."},{"key":"1437_CR21","doi-asserted-by":"publisher","first-page":"e2001207","DOI":"10.1002\/smtd.202001207","volume":"5","author":"MV Monteiro","year":"2021","unstructured":"Monteiro, M. V., Gaspar, V. M., Mendes, L., Duarte, I. F. & Mano, J. F. Stratified 3D microtumors as organotypic testing platforms for screening pancreatic cancer therapies. Small Methods 5, e2001207 (2021).","journal-title":"Small Methods"},{"key":"1437_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41378-022-00370-6","volume":"8","author":"MR Haque","year":"2022","unstructured":"Haque, M. R. et al. Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment. Microsyst. Nanoeng. 8, 36 (2022).","journal-title":"Microsyst. Nanoeng."},{"key":"1437_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303088","volume":"11","author":"D Choi","year":"2024","unstructured":"Choi, D. et al. Microfluidic organoid cultures derived from pancreatic cancer biopsies for personalized testing of chemotherapy and immunotherapy. Adv. Sci (Weinh). 11, e2303088 (2024).","journal-title":"Adv. Sci (Weinh)."},{"key":"1437_CR24","doi-asserted-by":"publisher","first-page":"56718","DOI":"10.1021\/acsami.4c11188","volume":"16","author":"MV Monteiro","year":"2024","unstructured":"Monteiro, M. V. et al. Embedded Bioprinting of Tumor-Scale Pancreatic Cancer-Stroma 3D Models for Preclinical Drug Screening. ACS. Appl. Mater. Interfaces. 16, 56718\u201356729 (2024).","journal-title":"ACS. Appl. Mater. Interfaces."},{"key":"1437_CR25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.18063\/ijb.v9i3.676","volume":"9","author":"B Huang","year":"2023","unstructured":"Huang, B., Wei, X., Chen, K., Wang, L. & Xu, M. Bioprinting of hydrogel beads to engineer pancreatic tumor-stroma microtissues for drug screening. Int. J. Bioprint. 9, 676 (2023).","journal-title":"Int. J. Bioprint."},{"key":"1437_CR26","doi-asserted-by":"crossref","unstructured":"Wei, X., Wu, Y., Chen, K., Wang, L. & Xu, M. Embedded bioprinted multicellular spheroids modeling pancreatic cancer bioarchitecture towards advanced drug therapy. J. Mater. Chem. B. 12, 1788\u20131797 (2024).","DOI":"10.1039\/D3TB02913A"},{"key":"1437_CR27","doi-asserted-by":"publisher","first-page":"e2001284","DOI":"10.1002\/adhm.202001284","volume":"10","author":"SM Kang","year":"2021","unstructured":"Kang, S. M., Kim, D., Lee, J. H., Takayama, S. & Park, J. Y. Engineered Microsystems for Spheroid and Organoid Studies. Adv. Healthc. Mater. 10, e2001284 (2021).","journal-title":"Adv. Healthc. Mater."},{"key":"1437_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202000608","volume":"9","author":"SJ Kim","year":"2020","unstructured":"Kim, S. J., Kim, E. M., Yamamoto, M., Park, H. & Shin, H. Engineering Multi-Cellular Spheroids for Tissue Engineering and Regenerative Medicine. Adv. Healthc. Mater. 9, e2000608 (2020).","journal-title":"Adv. Healthc. Mater."},{"key":"1437_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41378-025-01098-9","volume":"11","author":"X Chen","year":"2025","unstructured":"Chen, X. et al. Integrated 3D microstructured digital microfluidic platform for advanced 3D cell culture. Microsyst. Nanoeng. 11, 239 (2025).","journal-title":"Microsyst. Nanoeng."},{"key":"1437_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41378-025-01077-0","volume":"11","author":"A Glia","year":"2025","unstructured":"Glia, A. et al. Spheromatrix: a paper-based platform for scalable 3D tumor model generation, cryopreservation, and high-throughput drug assessment. Microsyst. Nanoeng. 11, 219 (2025).","journal-title":"Microsyst. Nanoeng."},{"key":"1437_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41378-021-00267-w","volume":"7","author":"F Qu","year":"2021","unstructured":"Qu, F. et al. Double emulsion-pretreated microwell culture for the in vitro production of multicellular spheroids and their in situ analysis. Microsyst. Nanoeng. 7, 38 (2021).","journal-title":"Microsyst. Nanoeng."},{"key":"1437_CR32","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1039\/D3LC01116J","volume":"24","author":"D Tian","year":"2024","unstructured":"Tian, D. et al. Rocking- and diffusion-based culture of tumor spheroids-on-a-chip. Lab. Chip. 24, 2561\u20132574 (2024).","journal-title":"Lab. Chip."},{"key":"1437_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.addr.2021.02.012","volume":"172","author":"H Liu","year":"2021","unstructured":"Liu, H., Shi, Y. & Qian, F. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts. Adv. Drug Deliv. Rev. 172, 37\u201351 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1437_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120077","volume":"251","author":"HY Tanaka","year":"2020","unstructured":"Tanaka, H. Y. et al. Heterotypic 3D pancreatic cancer model with tunable proportion of fibrotic elements. Biomaterials 251, 120077 (2020).","journal-title":"Biomaterials"},{"key":"1437_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.actbio.2016.11.072","volume":"49","author":"V Brancato","year":"2017","unstructured":"Brancato, V. et al. Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer. Acta Biomater 49, 152\u2013166 (2017).","journal-title":"Acta Biomater"},{"key":"1437_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71372-9","volume":"14","author":"E Struth","year":"2024","unstructured":"Struth, E. et al. Drug resistant pancreatic cancer cells exhibit altered biophysical interactions with stromal fibroblasts in imaging studies of 3D co-culture models. Sci. Rep. 14, 20698 (2024).","journal-title":"Sci. Rep."},{"key":"1437_CR37","first-page":"360","volume":"25","author":"M Ermis","year":"2023","unstructured":"Ermis, M. et al. Tunable hybrid hydrogels with multicellular spheroids for modeling desmoplastic pancreatic cancer. Bioact. Mater. 25, 360\u2013373 (2023).","journal-title":"Bioact. Mater."},{"key":"1437_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jconrel.2016.09.004","volume":"244","author":"DL Priwitaningrum","year":"2016","unstructured":"Priwitaningrum, D. L. et al. Tumor stroma-containing 3D spheroid arrays: A tool to study nanoparticle penetration. J. Control Release. 244, 257\u2013268 (2016).","journal-title":"J. Control Release."},{"key":"1437_CR39","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/bjc.1995.200","volume":"71","author":"A Ito","year":"1995","unstructured":"Ito, A. et al. Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br J. Cancer. 71, 1039\u20131045 (1995).","journal-title":"Br J. Cancer."},{"key":"1437_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-cancerbio-030518-055425","volume":"4","author":"A Francou","year":"2020","unstructured":"Francou, A. & Anderson, K. V. The Epithelial-to-Mesenchymal Transition (EMT) in Development and Cancer. Annu. Rev. Cancer. Biol. 4, 197\u2013220 (2020).","journal-title":"Annu. Rev. Cancer. Biol."},{"key":"1437_CR41","doi-asserted-by":"publisher","first-page":"7638","DOI":"10.1021\/acs.analchem.0c00408","volume":"92","author":"L Zhao","year":"2020","unstructured":"Zhao, L., Liu, Y., Liu, Y., Zhang, M. & Zhang, X. Microfluidic control of tumor and stromal cell spheroids pairing and merging for three-dimensional metastasis study. Anal. Chem. 92, 7638\u20137645 (2020).","journal-title":"Anal. Chem."},{"key":"1437_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrclinonc.2010.16","volume":"7","author":"J Berlin","year":"2010","unstructured":"Berlin, J. & Benson, A. B. 3rd Chemotherapy: Gemcitabine remains the standard of care for pancreatic cancer. Nat. Rev. Clin. Oncol. 7, 135\u2013137 (2010).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1437_CR43","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1111\/cas.13630","volume":"109","author":"HY Tanaka","year":"2018","unstructured":"Tanaka, H. Y. & Kano, M. R. Stromal barriers to nanomedicine penetration in the pancreatic tumor microenvironment. Cancer Sci 109, 2085\u20132092 (2018).","journal-title":"Cancer Sci"},{"key":"1437_CR44","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3390\/cancers15030724","volume":"15","author":"HY Tanaka","year":"2023","unstructured":"Tanaka, H. Y. et al. Therapeutic strategies to overcome fibrotic barriers to nanomedicine in the pancreatic tumor microenvironment. Cancers (Basel) 15, 724 (2023).","journal-title":"Cancers (Basel)"},{"key":"1437_CR45","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.addr.2015.07.007","volume":"99","author":"G Ishii","year":"2016","unstructured":"Ishii, G., Ochiai, A. & Neri, S. Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment. Adv. Drug Deliv. Rev. 99, 186\u2013196 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1437_CR46","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s13046-022-02519-7","volume":"41","author":"S Schuth","year":"2022","unstructured":"Schuth, S. et al. Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system. J. Exp. Clin. Cancer Res. 41, 312 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1437_CR47","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1158\/0008-5472.CAN-12-3180","volume":"73","author":"S Kozono","year":"2013","unstructured":"Kozono, S. et al. Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells. Cancer. Res. 73, 2345\u20132356 (2013).","journal-title":"Cancer. Res."},{"key":"1437_CR48","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41416-024-02631-9","volume":"130","author":"Y Lei","year":"2024","unstructured":"Lei, Y. et al. Pirfenidone alleviates fibrosis by acting on tumour-stroma interplay in pancreatic cancer. Br. J. Cancer. 130, 1505\u20131516 (2024).","journal-title":"Br. J. Cancer."}],"container-title":["Microsystems & Nanoengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41378-026-01437-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41378-026-01437-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41378-026-01437-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T03:24:39Z","timestamp":1788146679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41378-026-01437-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1437"],"URL":"https:\/\/doi.org\/10.1038\/s41378-026-01437-4","relation":{},"ISSN":["2055-7434"],"issn-type":[{"value":"2055-7434","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"310"}}